AI assistant
Sending…
LIVE VENTURES Inc — Director's Dealing 2014
Oct 23, 2014
34508_dirs_2014-10-23_01c6d9c2-d028-47fe-8697-d4f1eb4ba8bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LIVEDEAL INC (LIVE)
CIK: 0001045742
Period of Report: 2014-10-23
Reporting Person: Isaac Jon (Director, CEO, CFO and President, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-10-23 | Common Stock, par value $0.001 per share | P | 25000 | $3.02 | Acquired | 8228245 | Direct |
| 2014-10-23 | Common Stock, par value $0.001 per share | P | 25000 | $3.04 | Acquired | 8253245 | Direct |
| 2014-10-23 | Common Stock, par value $0.001 per share | P | 25000 | $3.055 | Acquired | 8278245 | Direct |
| 2014-10-23 | Common Stock, par value $0.001 per share | P | 25000 | $3.12 | Acquired | 8303245 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-15 | Stock Option (Right to Buy) | $0.5533 | A | 450000 | Acquired | 2023-01-14 | Common Stock (450000) | Direct |
| 2013-01-15 | Stock Option (Right to Buy) | $0.8333 | A | 450000 | Acquired | 2023-01-14 | Common Stock (450000) | Direct |
| 2013-01-15 | Stock Option (Right to Buy) | $1.11 | A | 450000 | Acquired | 2023-01-14 | Common Stock (450000) | Direct |
Footnotes
F1: The option vests and becomes exercisable on January 26, 2015.
F2: The option vests and becomes exercisable on January 26, 2016.
F3: The options were issued under the Company's incentive plan. There was no consideration paid for the issuance.
More from LIVE VENTURES Inc
Proxy Solicitation & Information Statement
2026
May 21
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Feb 12
Interim / Quarterly Report
2026
Feb 12
Director's Dealing
2025
Dec 23
Annual Report
2025
Dec 17
Regulatory Filings
2025
Dec 11
Interim / Quarterly Report
2025
Aug 8
Regulatory Filings
2025
Aug 7